The Australian medical landscape is buzzing with the introduction of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist showing significant results in clinical trials for treating obesity. https://webcastlist.com/story23273777/retatrutide-australia-a-new-hope-for-weight-management